Tyber Medical received FDA 510(k) clearance of BioTy™ Modified Surface Treatment for use on its Headless Screw System. Further, the company expanded its exclusive licensing agreement with Northeastern University to further enhance BioTy proprietary technology and IP.
BioTy nano-scale technology is designed to modify the surface characteristics of medical devices for advanced indications that are yet to be disclosed, but are under development through FDA’s review process.
Tyber Medical received FDA 510(k) clearance of BioTy™ Modified Surface Treatment for use on its Headless Screw System. Further, the company expanded its exclusive licensing agreement with Northeastern University to further enhance BioTy proprietary technology and IP.
BioTy nano-scale technology is designed to modify the surface...
Tyber Medical received FDA 510(k) clearance of BioTy™ Modified Surface Treatment for use on its Headless Screw System. Further, the company expanded its exclusive licensing agreement with Northeastern University to further enhance BioTy proprietary technology and IP.
BioTy nano-scale technology is designed to modify the surface characteristics of medical devices for advanced indications that are yet to be disclosed, but are under development through FDA’s review process.
Copy to clipboard 
